• Home
  • Study Details
By physician referral or invitation only

The COVID-19 Cancer Study (CovCS)

The COVID-19 pandemic is shifting everyday life for Americans with profound economic, health, and psychological consequences. The impact of these disruptions on cancer survivors specifically warrants investigation, as this population may be at increased risk for serious illness complication. The goal of the proposed COVID-19 Cancer Study (CovCS) is to establish the feasibility and acceptability of conducting a contact study on the COVID-19 experiences of cancer survivors in North Carolina. CovCS will determine feasibility and acceptability of conducting participant-contact research during the COVID-19 pandemic with cancer survivors (colorectal, lung, bladder, kidney, breast and prostate cancer) and controls.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team


Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Erin Kent
Health Policy and Management

Study Type

Behavioral or Social

Study Topics

Cancer (Bladder, Colorectal, Cervical, Head and Neck, Kidney, Lung, Melanoma, Prostate, Other Cancers)

IRB Number


logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.